The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines
Witold Owczarek(Wojskowy Instytut Medycyny Lotniczej), Joanna Narbutt(ENT and Allergy), Rafał Czajkowski(Nicolaus Copernicus University), Adam Reich(Rzeszów University of Technology), Aleksandra Lesiak(Medical University of Lodz), Iwona Zerda, Irena Walecka(Ministry of Interior and Administration)
Cited by 43
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
|British Journal of Dermatology|2020|590
Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus
|Acta Dermato Venereologica|2012|579
Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus
|Acta Dermato Venereologica|2012|502